• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症中的泛素-蛋白酶体系统,DNA 修复中的主要参与者。第 1 部分:翻译后调控。

The ubiquitin-proteasome system in cancer, a major player in DNA repair. Part 1: post-translational regulation.

机构信息

Division of Medical Oncology, University Hospital of Larissa, Larissa, Greece.

出版信息

J Cell Mol Med. 2009 Sep;13(9B):3006-18. doi: 10.1111/j.1582-4934.2009.00824.x. Epub 2009 Jun 11.

DOI:10.1111/j.1582-4934.2009.00824.x
PMID:19522845
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4516461/
Abstract

DNA repair is a fundamental cellular function, indispensable for cell survival, especially in conditions of exposure to environmental or pharmacological effectors of DNA damage. The regulation of this function requires a flexible machinery to orchestrate the reversal of harmful DNA lesions by making use of existing proteins as well as inducible gene products. The accumulation of evidence for the involvement of ubiquitin-proteasome system (UPS) in DNA repair pathways, that is reviewed here, has expanded its role from a cellular waste disposal basket to a multi-dimensional regulatory system. This review is the first of two that attempt to illustrate the nature and interactions of all different DNA repair pathways where UPS is demonstrated to be involved, with special focus on cancer- and chemotherapy-related DNA-damage repair. In this first review, we will be presenting the proteolytic and non-proteolytic roles of UPS in the post-translational regulation of DNA repair proteins, while the second review will focus on the UPS-dependent transcriptional response of DNA repair after DNA damage and stress.

摘要

DNA 修复是一种基本的细胞功能,对细胞存活至关重要,尤其是在暴露于环境或药理学 DNA 损伤效应物的情况下。该功能的调节需要一个灵活的机制,通过利用现有蛋白质和诱导基因产物来协调有害 DNA 损伤的逆转。越来越多的证据表明泛素-蛋白酶体系统 (UPS) 参与 DNA 修复途径,本文对此进行了综述,其作用已从细胞废物处理篮扩展为多维调节系统。这是两篇综述中的第一篇,旨在说明 UPS 参与的所有不同 DNA 修复途径的性质和相互作用,特别关注与癌症和化疗相关的 DNA 损伤修复。在第一篇综述中,我们将介绍 UPS 在 DNA 修复蛋白的翻译后调节中的蛋白水解和非蛋白水解作用,而第二篇综述将重点介绍 DNA 损伤和应激后 UPS 依赖的 DNA 修复的转录反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed8b/4516461/76ba00109ff6/jcmm0013-3006-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed8b/4516461/0189f724ef7a/jcmm0013-3006-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed8b/4516461/76ba00109ff6/jcmm0013-3006-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed8b/4516461/0189f724ef7a/jcmm0013-3006-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed8b/4516461/76ba00109ff6/jcmm0013-3006-f2.jpg

相似文献

1
The ubiquitin-proteasome system in cancer, a major player in DNA repair. Part 1: post-translational regulation.癌症中的泛素-蛋白酶体系统,DNA 修复中的主要参与者。第 1 部分:翻译后调控。
J Cell Mol Med. 2009 Sep;13(9B):3006-18. doi: 10.1111/j.1582-4934.2009.00824.x. Epub 2009 Jun 11.
2
The ubiquitin-proteasome system in cancer, a major player in DNA repair. Part 2: transcriptional regulation.癌症中的泛素-蛋白酶体系统是 DNA 修复的主要参与者。第 2 部分:转录调控。
J Cell Mol Med. 2009 Sep;13(9B):3019-31. doi: 10.1111/j.1582-4934.2009.00825.x. Epub 2009 Jun 11.
3
Proteolytic and non-proteolytic roles of ubiquitin and the ubiquitin proteasome system in transcriptional regulation.泛素及泛素蛋白酶体系统在转录调控中的蛋白水解和非蛋白水解作用
Biochim Biophys Acta. 2011 Feb;1809(2):150-5. doi: 10.1016/j.bbagrm.2010.11.006. Epub 2010 Dec 22.
4
The Ubiquitin Proteasome Pathway (UPP) in the regulation of cell cycle control and DNA damage repair and its implication in tumorigenesis.泛素蛋白酶体途径(UPP)在细胞周期调控和DNA损伤修复中的作用及其在肿瘤发生中的意义。
Int J Clin Exp Pathol. 2012;5(8):726-38. Epub 2012 Oct 1.
5
The ubiquitin-proteasome system and cancer.泛素-蛋白酶体系统与癌症。
Essays Biochem. 2005;41:187-203. doi: 10.1042/EB0410187.
6
The vital link between the ubiquitin-proteasome pathway and DNA repair: impact on cancer therapy.泛素-蛋白酶体途径与DNA修复之间的重要联系:对癌症治疗的影响。
Cancer Lett. 2009 Sep 28;283(1):1-9. doi: 10.1016/j.canlet.2008.12.030. Epub 2009 Feb 6.
7
Proteasome function is required for DNA damage response and fanconi anemia pathway activation.蛋白酶体功能是DNA损伤反应和范可尼贫血途径激活所必需的。
Cancer Res. 2007 Aug 1;67(15):7395-405. doi: 10.1158/0008-5472.CAN-07-1015.
8
[The ubiquitin-proteasome proteolytic pathway and tumorigenesis].[泛素-蛋白酶体蛋白水解途径与肿瘤发生]
Yi Chuan. 2006 Dec;28(12):1591-6. doi: 10.1360/yc-006-1591.
9
Cellular ubiquitination and proteasomal functions positively modulate mammalian nucleotide excision repair.细胞泛素化和蛋白酶体功能正向调节哺乳动物核苷酸切除修复。
Mol Carcinog. 2005 Jan;42(1):53-64. doi: 10.1002/mc.20065.
10
Dynamic Behavior of the RNA Polymerase II and the Ubiquitin Proteasome System During the Neuronal DNA Damage Response to Ionizing Radiation.电离辐射诱导神经元DNA损伤反应过程中RNA聚合酶II与泛素蛋白酶体系统的动态行为
Mol Neurobiol. 2016 Dec;53(10):6799-6808. doi: 10.1007/s12035-015-9565-8. Epub 2015 Dec 11.

引用本文的文献

1
The DYT6 dystonia causative protein THAP1 is responsible for proteasome activity via PSMB5 transcriptional regulation.DYT6型肌张力障碍致病蛋白THAP1通过PSMB5转录调控作用来负责蛋白酶体活性。
Nat Commun. 2025 Feb 14;16(1):1600. doi: 10.1038/s41467-025-56867-x.
2
Protocatechuic aldehyde acts synergistically with dacarbazine to augment DNA double-strand breaks and promote apoptosis in cutaneous melanoma cells.原儿茶醛与达卡巴嗪协同作用增强皮肤黑素瘤细胞的 DNA 双链断裂并促进细胞凋亡。
BMC Complement Med Ther. 2023 Apr 6;23(1):111. doi: 10.1186/s12906-023-03933-w.
3
Hrq1/RECQL4 regulation is critical for preventing aberrant recombination during DNA intrastrand crosslink repair and is upregulated in breast cancer.

本文引用的文献

1
Ku80 removal from DNA through double strand break-induced ubiquitylation.通过双链断裂诱导的泛素化作用从DNA上去除Ku80
J Cell Biol. 2008 Aug 11;182(3):467-79. doi: 10.1083/jcb.200802146. Epub 2008 Aug 4.
2
PCNA modifications for regulation of post-replication repair pathways.用于调控复制后修复途径的增殖细胞核抗原修饰。
Mol Cells. 2008 Jul 31;26(1):5-11. Epub 2008 Jun 4.
3
Rad52 sumoylation and its involvement in the efficient induction of homologous recombination.Rad52的类泛素化修饰及其在高效诱导同源重组中的作用。
HRQ1/RECQL4 的调控对于防止 DNA 链内交联修复过程中的异常重组至关重要,并在乳腺癌中上调。
PLoS Genet. 2022 Sep 20;18(9):e1010122. doi: 10.1371/journal.pgen.1010122. eCollection 2022 Sep.
4
Revisiting the Function of p21 in DNA Repair: The Influence of Protein Interactions and Stability.重新审视 p21 在 DNA 修复中的功能:蛋白相互作用和稳定性的影响。
Int J Mol Sci. 2022 Jun 24;23(13):7058. doi: 10.3390/ijms23137058.
5
Debulking of topoisomerase DNA-protein crosslinks (TOP-DPC) by the proteasome, non-proteasomal and non-proteolytic pathways.拓扑异构酶 DNA-蛋白交联(TOP-DPC)通过蛋白酶体、非蛋白酶体和非蛋白水解途径的去稳定化。
DNA Repair (Amst). 2020 Oct;94:102926. doi: 10.1016/j.dnarep.2020.102926. Epub 2020 Jul 10.
6
Identification of deubiquitinase targets of isothiocyanates using SILAC-assisted quantitative mass spectrometry.使用稳定同位素标记氨基酸细胞培养法辅助的定量质谱分析法鉴定异硫氰酸酯的去泛素化酶作用靶点。
Oncotarget. 2017 Apr 20;8(31):51296-51316. doi: 10.18632/oncotarget.17261. eCollection 2017 Aug 1.
7
Interactome Analysis Reveals a Novel Role for RAD6 in the Regulation of Proteasome Activity and Localization in Response to DNA Damage.相互作用组分析揭示了RAD6在响应DNA损伤时对蛋白酶体活性和定位调控中的新作用。
Mol Cell Biol. 2017 Mar 1;37(6). doi: 10.1128/MCB.00419-16. Print 2017 Mar 15.
8
The Hsp90 inhibitor SNX-7081 is synergistic with fludarabine nucleoside via DNA damage and repair mechanisms in human, p53-negative chronic lymphocytic leukemia.在人p53阴性慢性淋巴细胞白血病中,热休克蛋白90(Hsp90)抑制剂SNX-7081通过DNA损伤和修复机制与氟达拉滨核苷具有协同作用。
Oncotarget. 2015 Dec 1;6(38):40981-97. doi: 10.18632/oncotarget.5715.
9
Efficacy of low dose temozolomide in combination with bortezomib in U87 glioma cells: a flow cytometric analysis.低剂量替莫唑胺联合硼替佐米对U87胶质瘤细胞的疗效:流式细胞术分析
Arch Med Sci. 2015 Apr 25;11(2):307-10. doi: 10.5114/aoms.2013.36919. Epub 2013 Aug 12.
10
Neuropeptide-inducible upregulation of proteasome activity precedes nuclear factor kappa B activation in androgen-independent prostate cancer cells.神经肽诱导的蛋白酶体活性上调先于核因子 κB 在雄激素非依赖性前列腺癌细胞中的激活。
Cancer Cell Int. 2012 Jun 20;12(1):31. doi: 10.1186/1475-2867-12-31.
DNA Repair (Amst). 2008 Jun 1;7(6):879-89. doi: 10.1016/j.dnarep.2008.02.005. Epub 2008 Apr 8.
4
Proteasome inhibitors remarkably prevent translesion replication in cancer cells but not normal cells.蛋白酶体抑制剂能显著阻止癌细胞中的跨损伤复制,但对正常细胞却无此作用。
Cancer Sci. 2008 May;99(5):863-71. doi: 10.1111/j.1349-7006.2008.00764.x. Epub 2008 Feb 24.
5
A yeast-based genetic screening to identify human proteins that increase homologous recombination.一项基于酵母的遗传筛选,用于鉴定可增强同源重组的人类蛋白质。
FEMS Yeast Res. 2008 May;8(3):351-61. doi: 10.1111/j.1567-1364.2007.00343.x. Epub 2008 Jan 30.
6
A targeted proteomic analysis of the ubiquitin-like modifier nedd8 and associated proteins.泛素样修饰因子Nedd8及其相关蛋白的靶向蛋白质组学分析。
J Proteome Res. 2008 Mar;7(3):1274-87. doi: 10.1021/pr700749v. Epub 2008 Feb 5.
7
Components of the ubiquitin-proteasome pathway compete for surfaces on Rad23 family proteins.泛素-蛋白酶体途径的组分竞争Rad23家族蛋白上的表面。
BMC Biochem. 2008 Jan 30;9:4. doi: 10.1186/1471-2091-9-4.
8
Oncogene-induced replication stress preferentially targets common fragile sites in preneoplastic lesions. A genome-wide study.癌基因诱导的复制应激优先靶向肿瘤前病变中的常见脆性位点。一项全基因组研究。
Oncogene. 2008 May 22;27(23):3256-64. doi: 10.1038/sj.onc.1210989. Epub 2007 Dec 17.
9
Polyubiquitylation of PARP-1 through ubiquitin K48 is modulated by activated DNA, NAD+, and dipeptides.通过泛素K48对PARP-1进行多聚泛素化修饰受活化的DNA、NAD⁺和二肽的调控。
J Cell Biochem. 2008 May 1;104(1):318-28. doi: 10.1002/jcb.21624.
10
Inhibitors of the proteasome suppress homologous DNA recombination in mammalian cells.蛋白酶体抑制剂可抑制哺乳动物细胞中的同源DNA重组。
Cancer Res. 2007 Sep 15;67(18):8536-43. doi: 10.1158/0008-5472.CAN-07-1166.